Pigmented villonodular synovitis (PVNS) is an aggressive lesion occurring primarily within joint spaces, usually the knee. A combination of surgery and radiotherapy may be helpful in difficult cases. Recurrence after operation is common. Histologically, PVNS is characterised by the proliferation of synovial lining cells and a heavy diffuse subintimal infiltrate of mononuclear cells, largely macrophages, among which are scattered multinucleated giant cells. Also, it is shown that the giant cells in the PVNS express all the phenotypical features of osteoclasts, including the ability to carry out lacunar resorption. This may account for the bone destruction associated with this aggressive synovial lesion. The osteoclastic cells, which cause bony destruction, are thought to be recruited from normal monocytic pre-osteoclasts by stromal cell expression of the ligand for receptor activator of nuclear factor kappa B (RANKL). Osteoprotegerin acts as a decoy receptor for RANKL blocking the process of osteoclast differentiation. Bisphosphonates stimulate the osteoprotegerin production by osteoblasts, which can lead to a significant reduction in RANKL. Therefore, bisphosphonates can be considered an adjuvant therapy for pigmented villonodular synovitis. Pigmented villonodular synovitis (PVNS) is an aggressive lesion occurring primarily within joint spaces, usually the knee. However, other sites including the hip, temporomandibular joint and bursa have been described. A combination of surgery and radiotherapy may be helpful in difficult cases, although recurrence after operation is common. The outcome after surgical resection has been affected negatively by tumour recurrence and additional bone destruction. Histologically, PVNS is characterised by the proliferation of synovial lining cells and a heavy diffuse subintimal infiltrate of mononuclear cells, largely macrophages, among which are scattered multinucleated giant cells; both mononuclear and multinucleated cells may contain phagocytosed haemosiderin or lipid. It is not known whether this giant-cell-rich synovial proliferation is reactive or neoplastic in nature, but in about one-third of cases PVNS behaves aggressively, causing para-articular osteolysis with the formation of multiple cysts in the bone. Ultrastructural studies of both the villous and nodular forms of PVNS have shown the presence of synovial type A macrophage-like cells and synovial type B fibroblast cells; the multinucleated cells show similar features to type A mononuclear cells, suggesting that they are formed by the fusion of type A cells. Multinucleated giant cells similar to those seen in PVNS may be found in a wide variety of giant cell lesions of bone and extraskeletal soft tissues. The giant cells from these various lesions have all been shown to be capable of lacunar bone resorption, a characteristic feature of osteoclasts. In skeletal giant cell containing lesions, such as giant cell tumour of the bone and giant cell reparative granuloma of the jaw, the giant cells exhibit all the defining characteristics of the osteoclast phenotype. Also, it is shown that the giant cells in the PVNS express all the phePublished online January 23, 2008. Address correspondence and reprint requests to: Hamid Namazi; E-mail: namazih@sums.ac.ir
Read full abstract